Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Issue Cover for Volume 29, Number 11—November 2023

Volume 29, Number 11—November 2023

[PDF - 14.53 MB - 234 pages]

Synopses

Medscape CME Activity
Campylobacter fetus Invasive Infections and Risks for Death, France, 2000–2021 [PDF - 853 KB - 9 pages]
S. Zayet et al.

Campylobacter fetus accounts for 1% of Campylobacter spp. infections, but prevalence of bacteremia and risk for death are high. To determine clinical features of C. fetus infections and risks for death, we conducted a retrospective observational study of all adult inpatients with a confirmed C. fetus infection in Nord Franche-Comté Hospital, Trevenans, France, during January 2000–December 2021. Among 991 patients with isolated Campylobacter spp. strains, we identified 39 (4%) with culture-positive C. fetus infections, of which 33 had complete records and underwent further analysis; 21 had documented bacteremia and 12 did not. Secondary localizations were reported for 7 (33%) patients with C. fetus bacteremia, of which 5 exhibited a predilection for vascular infections (including 3 with mycotic aneurysm). Another 7 (33%) patients with C. fetus bacteremia died within 30 days. Significant risk factors associated with death within 30 days were dyspnea, quick sequential organ failure assessment score >2 at admission, and septic shock.

EID Zayet S, Klopfenstein T, Gendrin V, Vuillemenot J, Plantin J, Toko L, et al. Campylobacter fetus Invasive Infections and Risks for Death, France, 2000–2021. Emerg Infect Dis. 2023;29(11):2189-2197. https://doi.org/10.3201/eid2911.230598
AMA Zayet S, Klopfenstein T, Gendrin V, et al. Campylobacter fetus Invasive Infections and Risks for Death, France, 2000–2021. Emerging Infectious Diseases. 2023;29(11):2189-2197. doi:10.3201/eid2911.230598.
APA Zayet, S., Klopfenstein, T., Gendrin, V., Vuillemenot, J., Plantin, J., Toko, L....Royer, P. (2023). Campylobacter fetus Invasive Infections and Risks for Death, France, 2000–2021. Emerging Infectious Diseases, 29(11), 2189-2197. https://doi.org/10.3201/eid2911.230598.

Congenital Mpox Syndrome (Clade I) in Stillborn Fetus after Placental Infection and Intrauterine Transmission, Democratic Republic of the Congo, 2008 [PDF - 1.70 MB - 5 pages]
D. A. Schwartz et al.

We report the autopsy pathology findings of a 21-week stillborn fetus with congenital mpox syndrome that occurred in the Democratic Republic of the Congo in 2008. The fetus acquired mpox from the mother after intrauterine transplacental monkeypox virus transmission. We confirmed monkeypox virus infection in the mother, fetus, and placenta by using a monkeypox virus–specific quantitative PCR. Subtyping of the virus was not performed, but the mother and fetus were almost certainly infected with the clade I variant that was endemic in the Democratic Republic of the Congo at the time. Risk for intrauterine infection appears to differ between virus clades, but clinicians should be aware of potential for intrauterine monkeypox virus transmission among pregnant persons during ongoing and future mpox outbreaks.

EID Schwartz DA, Mbala-Kingebeni P, Patterson K, Huggins JW, Pittman PR. Congenital Mpox Syndrome (Clade I) in Stillborn Fetus after Placental Infection and Intrauterine Transmission, Democratic Republic of the Congo, 2008. Emerg Infect Dis. 2023;29(11):2198-2202. https://doi.org/10.3201/eid2911.230606
AMA Schwartz DA, Mbala-Kingebeni P, Patterson K, et al. Congenital Mpox Syndrome (Clade I) in Stillborn Fetus after Placental Infection and Intrauterine Transmission, Democratic Republic of the Congo, 2008. Emerging Infectious Diseases. 2023;29(11):2198-2202. doi:10.3201/eid2911.230606.
APA Schwartz, D. A., Mbala-Kingebeni, P., Patterson, K., Huggins, J. W., & Pittman, P. R. (2023). Congenital Mpox Syndrome (Clade I) in Stillborn Fetus after Placental Infection and Intrauterine Transmission, Democratic Republic of the Congo, 2008. Emerging Infectious Diseases, 29(11), 2198-2202. https://doi.org/10.3201/eid2911.230606.

Medscape CME Activity
Group A Streptococcus Primary Peritonitis in Children, New Zealand [PDF - 916 KB - 7 pages]
A. Taylor et al.

Group A Streptococcus (GAS) primary peritonitis is a rare cause of pediatric acute abdomen (sudden onset of severe abdominal pain); only 26 pediatric cases have been reported in the English language literature since 1980. We discuss 20 additional cases of pediatric primary peritonitis caused by GAS among patients at Starship Children’s Hospital, Auckland, New Zealand, during 2010–2022. We compare identified cases of GAS primary peritonitis to cases described in the existing pediatric literature. As rates of rates of invasive GAS increase globally, clinicians should be aware of this cause of unexplained pediatric acute abdomen.

EID Taylor A, Elliott BM, Atkinson J, Roberts S, Voss L, Best EJ, et al. Group A Streptococcus Primary Peritonitis in Children, New Zealand. Emerg Infect Dis. 2023;29(11):2203-2209. https://doi.org/10.3201/eid2911.230211
AMA Taylor A, Elliott BM, Atkinson J, et al. Group A Streptococcus Primary Peritonitis in Children, New Zealand. Emerging Infectious Diseases. 2023;29(11):2203-2209. doi:10.3201/eid2911.230211.
APA Taylor, A., Elliott, B. M., Atkinson, J., Roberts, S., Voss, L., Best, E. J....Webb, R. (2023). Group A Streptococcus Primary Peritonitis in Children, New Zealand. Emerging Infectious Diseases, 29(11), 2203-2209. https://doi.org/10.3201/eid2911.230211.

Detection of Novel US Neisseria meningitidis Urethritis Clade Subtypes in Japan [PDF - 1.00 MB - 8 pages]
H. Takahashi et al.

Neisseria meningitidis causes invasive meningococcal diseases and has also been identified as a causative agent of sexually transmitted infections, including urethritis. Unencapsulated sequence type 11 meningococci containing the gonococcal aniA-norB locus and belonging to the United States N. meningitidis urethritis clade (US_NmUC) are causative agents of urethral infections in the United States, predominantly among men who have sex with men. We identified 2 subtypes of unencapsulated sequence type 11 meningococci in Japan that were phylogenetically close to US_NmUC, designated as the Japan N. meningitidis urethritis clade (J_NmUC). The subtypes were characterized by PCR, serologic testing, and whole-genome sequencing. Our study suggests that an ancestor of US_NmUC and J_NmUS urethritis-associated meningococci is disseminated worldwide. Global monitoring of urethritis-associated N. meningitidis isolates should be performed to further characterize microbiologic and epidemiologic characteristics of urethritis clade meningococci.

EID Takahashi H, Morita M, Yasuda M, Ohama Y, Kobori Y, Kojima M, et al. Detection of Novel US Neisseria meningitidis Urethritis Clade Subtypes in Japan. Emerg Infect Dis. 2023;29(11):2210-2217. https://doi.org/10.3201/eid2911.231082
AMA Takahashi H, Morita M, Yasuda M, et al. Detection of Novel US Neisseria meningitidis Urethritis Clade Subtypes in Japan. Emerging Infectious Diseases. 2023;29(11):2210-2217. doi:10.3201/eid2911.231082.
APA Takahashi, H., Morita, M., Yasuda, M., Ohama, Y., Kobori, Y., Kojima, M....Ohnishi, M. (2023). Detection of Novel US Neisseria meningitidis Urethritis Clade Subtypes in Japan. Emerging Infectious Diseases, 29(11), 2210-2217. https://doi.org/10.3201/eid2911.231082.

Clinical Manifestations and Genomic Evaluation of Melioidosis Outbreak among Children after Sporting Event, Australia [PDF - 5.32 MB - 11 pages]
S. Smith et al.

Melioidosis, caused by the environmental gram-negative bacterium Burkholderia pseudomallei, usually develops in adults with predisposing conditions and in Australia more commonly occurs during the monsoonal wet season. We report an outbreak of 7 cases of melioidosis in immunocompetent children in Australia. All the children had participated in a single-day sporting event during the dry season in a tropical region of Australia, and all had limited cutaneous disease. All case-patients had an adverse reaction to oral trimethoprim/sulfamethoxazole treatment, necessitating its discontinuation. We describe the clinical features, environmental sampling, genomic epidemiologic investigation, and public health response to the outbreak. Management of this outbreak shows the potential benefits of making melioidosis a notifiable disease. The approach used could also be used as a framework for similar outbreaks in the future.

EID Smith S, Marquardt T, Jennison AV, D’Addona A, Stewart J, Yarwood T, et al. Clinical Manifestations and Genomic Evaluation of Melioidosis Outbreak among Children after Sporting Event, Australia. Emerg Infect Dis. 2023;29(11):2218-2228. https://doi.org/10.3201/eid2911.230951
AMA Smith S, Marquardt T, Jennison AV, et al. Clinical Manifestations and Genomic Evaluation of Melioidosis Outbreak among Children after Sporting Event, Australia. Emerging Infectious Diseases. 2023;29(11):2218-2228. doi:10.3201/eid2911.230951.
APA Smith, S., Marquardt, T., Jennison, A. V., D’Addona, A., Stewart, J., Yarwood, T....Hanson, J. (2023). Clinical Manifestations and Genomic Evaluation of Melioidosis Outbreak among Children after Sporting Event, Australia. Emerging Infectious Diseases, 29(11), 2218-2228. https://doi.org/10.3201/eid2911.230951.

Outbreak of Pandoraea commovens Infections among Non–Cystic Fibrosis Intensive Care Patients, Germany, 2019–2021 [PDF - 1.84 MB - 9 pages]
T. Kruis et al.

Pandoraea spp. are gram-negative, nonfermenting rods mainly known to infect patients with cystic fibrosis (CF). Outbreaks have been reported from several CF centers. We report a Pandoraea spp. outbreak comprising 24 non-CF patients at a large university hospital and a neighboring heart center in Germany during July 2019–December 2021. Common features in the patients were critical illness, invasive ventilation, antimicrobial pretreatment, and preceding surgery. Complicated and relapsing clinical courses were observed in cases with intraabdominal infections but not those with lower respiratory tract infections. Genomic analysis of 15 isolates identified Pandoraea commovens as the genetically most similar species and confirmed the clonality of the outbreak strain, designated P. commovens strain LB-19-202-79. The strain exhibited resistance to most antimicrobial drugs except ampicillin/sulbactam, imipenem, and trimethoprim/sulfamethoxazole. Our findings suggest Pandoraea spp. can spread among non-CF patients and underscore that clinicians and microbiologists should be vigilant in detecting and assessing unusual pathogens.

EID Kruis T, Menzel P, Schwarzer R, Wiesener S, Schoenrath F, Klefisch F, et al. Outbreak of Pandoraea commovens Infections among Non–Cystic Fibrosis Intensive Care Patients, Germany, 2019–2021. Emerg Infect Dis. 2023;29(11):2229-2237. https://doi.org/10.3201/eid2911.230493
AMA Kruis T, Menzel P, Schwarzer R, et al. Outbreak of Pandoraea commovens Infections among Non–Cystic Fibrosis Intensive Care Patients, Germany, 2019–2021. Emerging Infectious Diseases. 2023;29(11):2229-2237. doi:10.3201/eid2911.230493.
APA Kruis, T., Menzel, P., Schwarzer, R., Wiesener, S., Schoenrath, F., Klefisch, F....Pfäfflin, F. (2023). Outbreak of Pandoraea commovens Infections among Non–Cystic Fibrosis Intensive Care Patients, Germany, 2019–2021. Emerging Infectious Diseases, 29(11), 2229-2237. https://doi.org/10.3201/eid2911.230493.
Research

Micro‒Global Positioning Systems for Identifying Nightly Opportunities for Marburg Virus Spillover to Humans by Egyptian Rousette Bats [PDF - 4.06 MB - 8 pages]
B. R. Amman et al.

Marburg virus disease, caused by Marburg and Ravn orthomarburgviruses, emerges sporadically in sub-Saharan Africa and is often fatal in humans. The natural reservoir is the Egyptian rousette bat (ERB), which sheds virus in saliva, urine, and feces. Frugivorous ERBs discard test-bitten and partially eaten fruit, potentially leaving infectious virus behind that could be consumed by other susceptible animals or humans. Historically, 8 of 17 known Marburg virus disease outbreaks have been linked to human encroachment on ERB habitats, but no linkage exists for the other 9 outbreaks, raising the question of how bats and humans might intersect, leading to virus spillover. We used micro‒global positioning systems to identify nightly ERB foraging locations. ERBs from a known Marburg virus‒infected population traveled long distances to feed in cultivated fruit trees near homes. Our results show that ERB foraging behavior represents a Marburg virus spillover risk to humans and plausibly explains the origins of some past outbreaks.

EID Amman BR, Schuh AJ, Akurut G, Kamugisha K, Namanya D, Sealy TK, et al. Micro‒Global Positioning Systems for Identifying Nightly Opportunities for Marburg Virus Spillover to Humans by Egyptian Rousette Bats. Emerg Infect Dis. 2023;29(11):2238-2245. https://doi.org/10.3201/eid2911.230362
AMA Amman BR, Schuh AJ, Akurut G, et al. Micro‒Global Positioning Systems for Identifying Nightly Opportunities for Marburg Virus Spillover to Humans by Egyptian Rousette Bats. Emerging Infectious Diseases. 2023;29(11):2238-2245. doi:10.3201/eid2911.230362.
APA Amman, B. R., Schuh, A. J., Akurut, G., Kamugisha, K., Namanya, D., Sealy, T. K....Towner, J. S. (2023). Micro‒Global Positioning Systems for Identifying Nightly Opportunities for Marburg Virus Spillover to Humans by Egyptian Rousette Bats. Emerging Infectious Diseases, 29(11), 2238-2245. https://doi.org/10.3201/eid2911.230362.

Global Phylogeography and Genomic Epidemiology of Carbapenem-Resistant blaOXA-232–Carrying Klebsiella pneumoniae Sequence Type 15 Lineage [PDF - 4.26 MB - 11 pages]
Y. Wu et al.

Prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) has compromised antimicrobial efficacy against severe infections worldwide. To monitor global spread, we conducted a comprehensive genomic epidemiologic study comparing sequences from 21 blaOXA-232–carrying CRKP isolates from China with K. pneumoniae sequence type (ST) 15 strains from 68 countries available in GenBank. Phylogenetic and phylogeographic analyses revealed all blaOXA-232–carrying CRKP isolates belonged to ST15 lineage and exhibited multidrug resistance. Analysis grouped 330 global blaOXA-232–carrying ST15 CRKP strains into 5 clades, indicating clonal transmission with small genetic distances among multiple strains. The lineage originated in the United States, then spread to Europe, Asia, Oceania, and Africa. Most recent common ancestor was traced back to 2000; mutations averaged ≈1.7 per year per genome. Our research helps identify key forces driving global spread of blaOXA-232–carrying CRKP ST15 lineage and emphasizes the importance of ongoing surveillance of epidemic CRKP.

EID Wu Y, Jiang T, He X, Shao J, Wu C, Mao W, et al. Global Phylogeography and Genomic Epidemiology of Carbapenem-Resistant blaOXA-232–Carrying Klebsiella pneumoniae Sequence Type 15 Lineage. Emerg Infect Dis. 2023;29(11):2246-2256. https://doi.org/10.3201/eid2911.230463
AMA Wu Y, Jiang T, He X, et al. Global Phylogeography and Genomic Epidemiology of Carbapenem-Resistant blaOXA-232–Carrying Klebsiella pneumoniae Sequence Type 15 Lineage. Emerging Infectious Diseases. 2023;29(11):2246-2256. doi:10.3201/eid2911.230463.
APA Wu, Y., Jiang, T., He, X., Shao, J., Wu, C., Mao, W....Ruan, Z. (2023). Global Phylogeography and Genomic Epidemiology of Carbapenem-Resistant blaOXA-232–Carrying Klebsiella pneumoniae Sequence Type 15 Lineage. Emerging Infectious Diseases, 29(11), 2246-2256. https://doi.org/10.3201/eid2911.230463.

SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022 [PDF - 1.21 MB - 9 pages]
R. A. Teran et al.

Understanding if persons with HIV (PWH) have a higher risk for SARS-CoV-2 reinfection may help tailor future COVID-19 public health guidance. To determine whether HIV infection was associated with increased risk for SARS-CoV-2 reinfection, we followed adult residents of Chicago, Illinois, USA, with SARS-CoV-2 longitudinally from their first reported infection through May 31, 2022. We matched SARS-CoV-2 laboratory data and COVID-19 vaccine administration data to Chicago’s Enhanced HIV/AIDS Reporting System. Among 453,587 Chicago residents with SARS-CoV-2, a total of 5% experienced a SARS-CoV-2 reinfection, including 192/2,886 (7%) PWH and 23,642/450,701 (5%) persons without HIV. We observed higher SARS-CoV-2 reinfection incidence rates among PWH (66 [95% CI 57–77] cases/1,000 person-years) than PWOH (50 [95% CI 49–51] cases/1,000 person-years). PWH had a higher adjusted rate of SARS-CoV-2 reinfection (1.46, 95% CI 1.27–1.68) than those without HIV. PWH should follow the recommended COVID-19 vaccine schedule, including booster doses.

EID Teran RA, Gagner A, Gretsch S, Lauritsen J, Galanto D, Walblay K, et al. SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022. Emerg Infect Dis. 2023;29(11):2257-2265. https://doi.org/10.3201/eid2911.230577
AMA Teran RA, Gagner A, Gretsch S, et al. SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022. Emerging Infectious Diseases. 2023;29(11):2257-2265. doi:10.3201/eid2911.230577.
APA Teran, R. A., Gagner, A., Gretsch, S., Lauritsen, J., Galanto, D., Walblay, K....Tabidze, I. (2023). SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022. Emerging Infectious Diseases, 29(11), 2257-2265. https://doi.org/10.3201/eid2911.230577.

Genotypic Evolution of Klebsiella pneumoniae Sequence Type 512 during Ceftazidime/Avibactam, Meropenem/Vaborbactam, and Cefiderocol Treatment, Italy [PDF - 1.81 MB - 9 pages]
G. Arcari et al.

In February 2022, a critically ill patient colonized with a carbapenem-resistant K. pneumoniae producing KPC-3 and VIM-1 carbapenemases was hospitalized for SARS-CoV-2 in the intensive care unit of Policlinico Umberto I hospital in Rome, Italy. During 95 days of hospitalization, ceftazidime/avibactam, meropenem/vaborbactam, and cefiderocol were administered consecutively to treat 3 respiratory tract infections sustained by different bacterial agents. Those therapies altered the resistome of K. pneumoniae sequence type 512 colonizing or infecting the patient during the hospitalization period. In vivo evolution of the K. pneumoniae sequence type 512 resistome occurred through plasmid loss, outer membrane porin alteration, and a nonsense mutation in the cirA siderophore receptor gene, resulting in high levels of cefiderocol resistance. Cross-selection can occur between K. pneumoniae and treatments prescribed for other infective agents. K. pneumoniae can stably colonize a patient, and antimicrobial-selective pressure can promote progressive K. pneumoniae resistome evolution, indicating a substantial public health threat.

EID Arcari G, Cecilia F, Oliva A, Polani R, Raponi G, Sacco F, et al. Genotypic Evolution of Klebsiella pneumoniae Sequence Type 512 during Ceftazidime/Avibactam, Meropenem/Vaborbactam, and Cefiderocol Treatment, Italy. Emerg Infect Dis. 2023;29(11):2266-2274. https://doi.org/10.3201/eid2911.230921
AMA Arcari G, Cecilia F, Oliva A, et al. Genotypic Evolution of Klebsiella pneumoniae Sequence Type 512 during Ceftazidime/Avibactam, Meropenem/Vaborbactam, and Cefiderocol Treatment, Italy. Emerging Infectious Diseases. 2023;29(11):2266-2274. doi:10.3201/eid2911.230921.
APA Arcari, G., Cecilia, F., Oliva, A., Polani, R., Raponi, G., Sacco, F....Carattoli, A. (2023). Genotypic Evolution of Klebsiella pneumoniae Sequence Type 512 during Ceftazidime/Avibactam, Meropenem/Vaborbactam, and Cefiderocol Treatment, Italy. Emerging Infectious Diseases, 29(11), 2266-2274. https://doi.org/10.3201/eid2911.230921.

Neurologic Effects of SARS-CoV-2 Transmitted among Dogs [PDF - 6.62 MB - 10 pages]
D. Kim et al.

SARS-CoV-2 induces illness and death in humans by causing systemic infections. Evidence suggests that SARS-CoV-2 can induce brain pathology in humans and other hosts. In this study, we used a canine transmission model to examine histopathologic changes in the brains of dogs infected with SARS-CoV-2. We observed substantial brain pathology in SARS-CoV-2–infected dogs, particularly involving blood–brain barrier damage resembling small vessel disease, including changes in tight junction proteins, reduced laminin levels, and decreased pericyte coverage. Furthermore, we detected phosphorylated tau, a marker of neurodegenerative disease, indicating a potential link between SARS-CoV-2–associated small vessel disease and neurodegeneration. Our findings of degenerative changes in the dog brain during SARS-CoV-2 infection emphasize the potential for transmission to other hosts and induction of similar signs and symptoms. The dynamic brain changes in dogs highlight that even asymptomatic individuals infected with SARS-CoV-2 may develop neuropathologic changes in the brain.

EID Kim D, Kim D, Kim K, Han S, Go H, Kim J, et al. Neurologic Effects of SARS-CoV-2 Transmitted among Dogs. Emerg Infect Dis. 2023;29(11):2275-2284. https://doi.org/10.3201/eid2911.230804
AMA Kim D, Kim D, Kim K, et al. Neurologic Effects of SARS-CoV-2 Transmitted among Dogs. Emerging Infectious Diseases. 2023;29(11):2275-2284. doi:10.3201/eid2911.230804.
APA Kim, D., Kim, D., Kim, K., Han, S., Go, H., Kim, J....Choi, I. (2023). Neurologic Effects of SARS-CoV-2 Transmitted among Dogs. Emerging Infectious Diseases, 29(11), 2275-2284. https://doi.org/10.3201/eid2911.230804.

Environmental Persistence and Disinfection of Lassa Virus [PDF - 1.39 MB - 7 pages]
M. Shaffer et al.

Lassa fever, caused by Lassa virus (LASV), is endemic to West Africa, where ≈300,000 illnesses and ≈5,000 deaths occur annually. LASV is primarily spread by infected multimammate rats via urine and fomites, highlighting the need to understand the environmental fate of LASV. We evaluated persistence of LASV Josiah and Sauerwald strains on surfaces, in aqueous solutions, and with sodium hypochlorite disinfection. Tested strains were more stable in deionized water (first-order rate constant [k] for Josiah, 0.23 days; for Sauerwald, k = 0.34 days) than primary influent wastewater (Josiah, k = 1.3 days; Sauerwald, k = 1.9 days). Both strains had similar decay rates on high-density polyethylene (Josiah, k = 4.3 days; Sauerwald, k = 2.3 days) and stainless steel (Josiah, k = 5.3 days; Sauerwald, k = 2.7 days). Sodium hypochlorite was highly effective at inactivating both strains. Our findings can inform future risk assessment and management efforts for Lassa fever.

EID Shaffer M, Fischer RJ, Gallogly S, Ginn O, Munster V, Bibby K. Environmental Persistence and Disinfection of Lassa Virus. Emerg Infect Dis. 2023;29(11):2285-2291. https://doi.org/10.3201/eid2911.230678
AMA Shaffer M, Fischer RJ, Gallogly S, et al. Environmental Persistence and Disinfection of Lassa Virus. Emerging Infectious Diseases. 2023;29(11):2285-2291. doi:10.3201/eid2911.230678.
APA Shaffer, M., Fischer, R. J., Gallogly, S., Ginn, O., Munster, V., & Bibby, K. (2023). Environmental Persistence and Disinfection of Lassa Virus. Emerging Infectious Diseases, 29(11), 2285-2291. https://doi.org/10.3201/eid2911.230678.

Simulation Study of Surveillance Strategies for Faster Detection of Novel SARS-CoV-2 Variants [PDF - 341 KB - 6 pages]
S. Patel et al.

Earlier global detection of novel SARS-CoV-2 variants gives governments more time to respond. However, few countries can implement timely national surveillance, resulting in gaps in monitoring. The United Kingdom implemented large-scale community and hospital surveillance, but experience suggests it might be faster to detect new variants through testing England arrivals for surveillance. We developed simulations of emergence and importation of novel variants with a range of infection hospitalization rates to the United Kingdom. We compared time taken to detect the variant though testing arrivals at England borders, hospital admissions, and the general community. We found that sampling 10%–50% of arrivals at England borders could confer a speed advantage of 3.5–6 weeks over existing community surveillance and 1.5–5 weeks (depending on infection hospitalization rates) over hospital testing. Directing limited global capacity for surveillance to highly connected ports could speed up global detection of novel SARS-CoV-2 variants.

EID Patel S, Cumming F, Mayers C, Charlett A, Riley S. Simulation Study of Surveillance Strategies for Faster Detection of Novel SARS-CoV-2 Variants. Emerg Infect Dis. 2023;29(11):2292-2297. https://doi.org/10.3201/eid2911.230492
AMA Patel S, Cumming F, Mayers C, et al. Simulation Study of Surveillance Strategies for Faster Detection of Novel SARS-CoV-2 Variants. Emerging Infectious Diseases. 2023;29(11):2292-2297. doi:10.3201/eid2911.230492.
APA Patel, S., Cumming, F., Mayers, C., Charlett, A., & Riley, S. (2023). Simulation Study of Surveillance Strategies for Faster Detection of Novel SARS-CoV-2 Variants. Emerging Infectious Diseases, 29(11), 2292-2297. https://doi.org/10.3201/eid2911.230492.

Human Salmonellosis Outbreak Linked to Salmonella Typhimurium Epidemic in Wild Songbirds, United States, 2020–2021 [PDF - 1.20 MB - 9 pages]
K. Patel et al.

Salmonella infection causes epidemic death in wild songbirds, with potential to spread to humans. In February 2021, public health officials in Oregon and Washington, USA, isolated a strain of Salmonella enterica serovar Typhimurium from humans and a wild songbird. Investigation by public health partners ultimately identified 30 illnesses in 12 states linked to an epidemic of Salmonella Typhimurium in songbirds. We report a multistate outbreak of human salmonellosis associated with songbirds, resulting from direct handling of sick and dead birds or indirect contact with contaminated birdfeeders. Companion animals might have contributed to the spread of Salmonella between songbirds and patients; the outbreak strain was detected in 1 ill dog, and a cat became ill after contact with a wild bird. This outbreak highlights a One Health issue where actions like regular cleaning of birdfeeders might reduce the health risk to wildlife, companion animals, and humans.

EID Patel K, Stapleton G, Trevejo RT, Tellier WT, Higa J, Adams JK, et al. Human Salmonellosis Outbreak Linked to Salmonella Typhimurium Epidemic in Wild Songbirds, United States, 2020–2021. Emerg Infect Dis. 2023;29(11):2298-2306. https://doi.org/10.3201/eid2911.230332
AMA Patel K, Stapleton G, Trevejo RT, et al. Human Salmonellosis Outbreak Linked to Salmonella Typhimurium Epidemic in Wild Songbirds, United States, 2020–2021. Emerging Infectious Diseases. 2023;29(11):2298-2306. doi:10.3201/eid2911.230332.
APA Patel, K., Stapleton, G., Trevejo, R. T., Tellier, W. T., Higa, J., Adams, J. K....Nichols, M. (2023). Human Salmonellosis Outbreak Linked to Salmonella Typhimurium Epidemic in Wild Songbirds, United States, 2020–2021. Emerging Infectious Diseases, 29(11), 2298-2306. https://doi.org/10.3201/eid2911.230332.

Prevalence of Undiagnosed Monkeypox Virus Infections during Global Mpox Outbreak, United States, June–September 2022 [PDF - 1.05 MB - 8 pages]
F. S. Minhaj et al.

Since May 2022, mpox has been identified in 108 countries without endemic disease; most cases have been in gay, bisexual, or other men who have sex with men. To determine number of missed cases, we conducted 2 studies during June–September 2022: a prospective serologic survey detecting orthopoxvirus antibodies among men who have sex with men in San Francisco, California, and a retrospective monkeypox virus PCR testing of swab specimens submitted for other infectious disease testing among all patients across the United States. The serosurvey of 225 participants (median age 34 years) detected 18 (8.0%) who were orthopoxvirus IgG positive and 3 (1.3%) who were also orthopoxvirus IgM positive. The retrospective PCR study of 1,196 patients (median age 30 years; 54.8% male) detected 67 (5.6%) specimens positive for monkeypox virus. There are likely few undiagnosed cases of mpox in regions where sexual healthcare is accessible and patient and clinician awareness about mpox is increased.

EID Minhaj FS, Singh V, Cohen SE, Townsend MB, Scott H, Szumowski J, et al. Prevalence of Undiagnosed Monkeypox Virus Infections during Global Mpox Outbreak, United States, June–September 2022. Emerg Infect Dis. 2023;29(11):2307-2314. https://doi.org/10.3201/eid2911.230940
AMA Minhaj FS, Singh V, Cohen SE, et al. Prevalence of Undiagnosed Monkeypox Virus Infections during Global Mpox Outbreak, United States, June–September 2022. Emerging Infectious Diseases. 2023;29(11):2307-2314. doi:10.3201/eid2911.230940.
APA Minhaj, F. S., Singh, V., Cohen, S. E., Townsend, M. B., Scott, H., Szumowski, J....Hutson, C. L. (2023). Prevalence of Undiagnosed Monkeypox Virus Infections during Global Mpox Outbreak, United States, June–September 2022. Emerging Infectious Diseases, 29(11), 2307-2314. https://doi.org/10.3201/eid2911.230940.

Duration of Enterovirus D68 RNA Shedding in the Upper Respiratory Tract and Transmission among Household Contacts, Colorado, USA [PDF - 844 KB - 10 pages]
H. Nguyen-Tran et al.

Enterovirus D68 (EV-D68) causes cyclical outbreaks of respiratory disease and acute flaccid myelitis. EV-D68 is primarily transmitted through the respiratory route, but the duration of shedding in the respiratory tract is unknown. We prospectively enrolled 9 hospitalized children with EV-D68 respiratory infection and 16 household contacts to determine EV-D68 RNA shedding dynamics in the upper respiratory tract through serial midturbinate specimen collections and daily symptom diaries. Five (31.3%) household contacts, including 3 adults, were EV-D68–positive. The median duration of EV-D68 RNA shedding in the upper respiratory tract was 12 (range 7–15) days from symptom onset. The most common symptoms were nasal congestion (100%), cough (92.9%), difficulty breathing (78.6%), and wheezing (57.1%). The median illness duration was 20 (range 11–24) days. Understanding the duration of RNA shedding can inform the expected rate and timing of EV-D68 detection in associated acute flaccid myelitis cases and help guide public health measures.

EID Nguyen-Tran H, Thompson C, Butler M, Miller KR, Pyle L, Jung S, et al. Duration of Enterovirus D68 RNA Shedding in the Upper Respiratory Tract and Transmission among Household Contacts, Colorado, USA. Emerg Infect Dis. 2023;29(11):2315-2324. https://doi.org/10.3201/eid2911.230947
AMA Nguyen-Tran H, Thompson C, Butler M, et al. Duration of Enterovirus D68 RNA Shedding in the Upper Respiratory Tract and Transmission among Household Contacts, Colorado, USA. Emerging Infectious Diseases. 2023;29(11):2315-2324. doi:10.3201/eid2911.230947.
APA Nguyen-Tran, H., Thompson, C., Butler, M., Miller, K. R., Pyle, L., Jung, S....Messacar, K. (2023). Duration of Enterovirus D68 RNA Shedding in the Upper Respiratory Tract and Transmission among Household Contacts, Colorado, USA. Emerging Infectious Diseases, 29(11), 2315-2324. https://doi.org/10.3201/eid2911.230947.

Risk Factors for Recent HIV Infections among Adults in 14 Countries in Africa Identified by Population-Based HIV Impact Assessment Surveys, 2015–2019 [PDF - 789 KB - 10 pages]
D. W. Currie et al.

Identifying persons who have newly acquired HIV infections is critical for characterizing the HIV epidemic direction. We analyzed pooled data from nationally representative Population-Based HIV Impact Assessment surveys conducted across 14 countries in Africa for recent infection risk factors. We included adults 15–49 years of age who had sex during the previous year and used a recent infection testing algorithm to distinguish recent from long-term infections. We collected risk factor information via participant interviews and assessed correlates of recent infection using multinomial logistic regression, incorporating each surveyʼs complex sampling design. Compared with HIV-negative persons, persons with higher odds of recent HIV infection were women, were divorced/separated/widowed, had multiple recent sex partners, had a recent HIV-positive sex partner or one with unknown status, and lived in communities with higher HIV viremia prevalence. Prevention programs focusing on persons at higher risk for HIV and their sexual partners will contribute to reducing HIV incidence.

EID Currie DW, West CA, Patel HK, Favaloro J, Asiimwe F, Ndagije F, et al. Risk Factors for Recent HIV Infections among Adults in 14 Countries in Africa Identified by Population-Based HIV Impact Assessment Surveys, 2015–2019. Emerg Infect Dis. 2023;29(11):2325-2334. https://doi.org/10.3201/eid2911.230703
AMA Currie DW, West CA, Patel HK, et al. Risk Factors for Recent HIV Infections among Adults in 14 Countries in Africa Identified by Population-Based HIV Impact Assessment Surveys, 2015–2019. Emerging Infectious Diseases. 2023;29(11):2325-2334. doi:10.3201/eid2911.230703.
APA Currie, D. W., West, C. A., Patel, H. K., Favaloro, J., Asiimwe, F., Ndagije, F....Voetsch, A. C. (2023). Risk Factors for Recent HIV Infections among Adults in 14 Countries in Africa Identified by Population-Based HIV Impact Assessment Surveys, 2015–2019. Emerging Infectious Diseases, 29(11), 2325-2334. https://doi.org/10.3201/eid2911.230703.

Systematic Review and Meta-analysis of Deaths Attributable to Antimicrobial Resistance, Latin America [PDF - 1.61 MB - 10 pages]
A. Ciapponi et al.

Antimicrobial resistance is a pressing global health concern, leading to 4.95 million deaths in 2019. We conducted a systematic review and meta-analysis to assess the lethality attributed to infections caused by multidrug-resistant organisms (MDROs) in Latin America and the Caribbean. A comprehensive search of major databases retrieved relevant studies from 2000–2022. We included 54 observational studies, primarily from Brazil, Argentina, and Colombia. The most commonly studied organism was methicillin-resistant Staphylococcus aureus. The overall unadjusted case fatality rate related to MDROs was 45.0%; higher adjusted lethality was observed in persons infected with MDROs than in those infected with other pathogens (adjusted odds ratio 1.93, 95% CI 1.58–2.37). A higher lethality rate was seen in patients who did not receive appropriate empirical treatment (odds ratio 2.27, 95% CI 1.44–3.56). These findings underscore the increased lethality associated with antimicrobial resistance in Latin America and the Caribbean.

EID Ciapponi A, Bardach A, Sandoval M, Palermo M, Navarro E, Espinal C, et al. Systematic Review and Meta-analysis of Deaths Attributable to Antimicrobial Resistance, Latin America. Emerg Infect Dis. 2023;29(11):2335-2344. https://doi.org/10.3201/eid2911.230753
AMA Ciapponi A, Bardach A, Sandoval M, et al. Systematic Review and Meta-analysis of Deaths Attributable to Antimicrobial Resistance, Latin America. Emerging Infectious Diseases. 2023;29(11):2335-2344. doi:10.3201/eid2911.230753.
APA Ciapponi, A., Bardach, A., Sandoval, M., Palermo, M., Navarro, E., Espinal, C....Quirós, R. (2023). Systematic Review and Meta-analysis of Deaths Attributable to Antimicrobial Resistance, Latin America. Emerging Infectious Diseases, 29(11), 2335-2344. https://doi.org/10.3201/eid2911.230753.
Dispatches

Three Cases of Tickborne Francisella tularensis Infection, Austria, 2022 [PDF - 1.35 MB - 4 pages]
F. Heger et al.

Tularemia is increasing in Austria. We report Francisella tularensis subspecies holarctica isolated from 3 patients who had been bitten by arthropods. Next-generation sequencing showed substantial isolate similarity. Clinicians should consider bloodstream F. tularensis infections for patients with signs/symptoms of ulceroglandular tularemia, and surveillance of potential vectors should be intensified.

EID Heger F, Schindler S, Pleininger S, Fueszl A, Blaschitz M, Lippert K, et al. Three Cases of Tickborne Francisella tularensis Infection, Austria, 2022. Emerg Infect Dis. 2023;29(11):2349-2352. https://doi.org/10.3201/eid2911.230460
AMA Heger F, Schindler S, Pleininger S, et al. Three Cases of Tickborne Francisella tularensis Infection, Austria, 2022. Emerging Infectious Diseases. 2023;29(11):2349-2352. doi:10.3201/eid2911.230460.
APA Heger, F., Schindler, S., Pleininger, S., Fueszl, A., Blaschitz, M., Lippert, K....Indra, A. (2023). Three Cases of Tickborne Francisella tularensis Infection, Austria, 2022. Emerging Infectious Diseases, 29(11), 2349-2352. https://doi.org/10.3201/eid2911.230460.

Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA [PDF - 830 KB - 5 pages]
M. K. Lash et al.

We assessed tecovirimat treatment equity for 3,740 mpox patients in New York, New York, USA, during the 2022 mpox emergency; 32.4% received tecovirimat. Treatment rates by race/ethnicity were 38.8% (White), 31.3% (Black/African American), 31.0% (Hispanic/Latino), and 30.1% (Asian/Pacific Islander/other). Future public health emergency responses must prioritize institutional and structural racism mitigation.

EID Lash MK, Latham NH, Chan P, Foote M, Garcia EA, Silverstein MF, et al. Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA. Emerg Infect Dis. 2023;29(11):2353-2357. https://doi.org/10.3201/eid2911.230814
AMA Lash MK, Latham NH, Chan P, et al. Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA. Emerging Infectious Diseases. 2023;29(11):2353-2357. doi:10.3201/eid2911.230814.
APA Lash, M. K., Latham, N. H., Chan, P., Foote, M., Garcia, E. A., Silverstein, M. F....McPherson, T. D. (2023). Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA. Emerging Infectious Diseases, 29(11), 2353-2357. https://doi.org/10.3201/eid2911.230814.

Hepatitis C Virus Elimination Program among Prison Inmates, Israel [PDF - 385 KB - 4 pages]
L. Eisen et al.

The Israeli Prison Services implemented a hepatitis C virus (HCV) elimination program in 2020. Inmates considered high risk for HCV were offered serology; HCV-seropositive participants were offered HCV RNA testing. Among participants, 7.0% had detectable HCV RNA and were offered antiviral drug therapy. This program reduced HCV burden among incarcerated persons.

EID Eisen L, Mor Z, Madar M, Rabinovitch R, Dadon Y, Sheffer R, et al. Hepatitis C Virus Elimination Program among Prison Inmates, Israel. Emerg Infect Dis. 2023;29(11):2358-2361. https://doi.org/10.3201/eid2911.230728
AMA Eisen L, Mor Z, Madar M, et al. Hepatitis C Virus Elimination Program among Prison Inmates, Israel. Emerging Infectious Diseases. 2023;29(11):2358-2361. doi:10.3201/eid2911.230728.
APA Eisen, L., Mor, Z., Madar, M., Rabinovitch, R., Dadon, Y., Sheffer, R....Goldstein, L. (2023). Hepatitis C Virus Elimination Program among Prison Inmates, Israel. Emerging Infectious Diseases, 29(11), 2358-2361. https://doi.org/10.3201/eid2911.230728.

Monkeypox Virus in Wastewater Samples from Santiago Metropolitan Region, Chile [PDF - 1.42 MB - 4 pages]
M. Ampuero et al.

Sewage surveillance provides useful epidemiologic and public health information on viral infections at the population level. We detected monkeypox virus DNA from sewage samples covering 85% of the population in Santiago Metropolitan Region Chile. We also isolated infective viruses from those samples. Wastewater surveillance could complement clinical surveillance for monkeypox virus.

EID Ampuero M, Martínez-Valdebenito C, Ferrés M, Soto-Rifo R, Gaggero A. Monkeypox Virus in Wastewater Samples from Santiago Metropolitan Region, Chile. Emerg Infect Dis. 2023;29(11):2358-2361. https://doi.org/10.3201/eid2911.230096
AMA Ampuero M, Martínez-Valdebenito C, Ferrés M, et al. Monkeypox Virus in Wastewater Samples from Santiago Metropolitan Region, Chile. Emerging Infectious Diseases. 2023;29(11):2358-2361. doi:10.3201/eid2911.230096.
APA Ampuero, M., Martínez-Valdebenito, C., Ferrés, M., Soto-Rifo, R., & Gaggero, A. (2023). Monkeypox Virus in Wastewater Samples from Santiago Metropolitan Region, Chile. Emerging Infectious Diseases, 29(11), 2358-2361. https://doi.org/10.3201/eid2911.230096.

Trends of Enterovirus D68 Concentrations in Wastewater, California, USA, February 2021–April 2023 [PDF - 862 KB - 4 pages]
A. B. Boehm et al.

In this retrospective study, we measured enterovirus D68 (EV-D68) genomic RNA in wastewater solids longitudinally at 2 California, USA, wastewater treatment plants twice per week for 26 months. EV-D68 RNA was undetectable except when concentrations increased from mid-July to mid-December 2022, which coincided with a peak in confirmed EV-D68 cases.

EID Boehm AB, Wadford DA, Hughes B, Duong D, Chen A, Padilla T, et al. Trends of Enterovirus D68 Concentrations in Wastewater, California, USA, February 2021–April 2023. Emerg Infect Dis. 2023;29(11):2362-2365. https://doi.org/10.3201/eid2911.231080
AMA Boehm AB, Wadford DA, Hughes B, et al. Trends of Enterovirus D68 Concentrations in Wastewater, California, USA, February 2021–April 2023. Emerging Infectious Diseases. 2023;29(11):2362-2365. doi:10.3201/eid2911.231080.
APA Boehm, A. B., Wadford, D. A., Hughes, B., Duong, D., Chen, A., Padilla, T....Wolfe, M. K. (2023). Trends of Enterovirus D68 Concentrations in Wastewater, California, USA, February 2021–April 2023. Emerging Infectious Diseases, 29(11), 2362-2365. https://doi.org/10.3201/eid2911.231080.

Erythema Migrans Caused by Borrelia spielmanii, France [PDF - 1.11 MB - 4 pages]
P. del Giudice et al.

We describe a rare case of early Lyme borreliosis in France caused by Borrelia spielmanii, which manifested as a large erythema chronicum migrans rash. The patient completely recovered after a 15-day course of amoxicillin. Absence of pathognomonic signs prevented distinguishing B. spielmanii from other etiologies as cause in this case-patient.

EID del Giudice P, Freychet F, Kopec L, Fenollar F, Eldin C, Velin M, et al. Erythema Migrans Caused by Borrelia spielmanii, France. Emerg Infect Dis. 2023;29(11):2366-2369. https://doi.org/10.3201/eid2911.230149
AMA del Giudice P, Freychet F, Kopec L, et al. Erythema Migrans Caused by Borrelia spielmanii, France. Emerging Infectious Diseases. 2023;29(11):2366-2369. doi:10.3201/eid2911.230149.
APA del Giudice, P., Freychet, F., Kopec, L., Fenollar, F., Eldin, C., Velin, M....Mediannikov, O. (2023). Erythema Migrans Caused by Borrelia spielmanii, France. Emerging Infectious Diseases, 29(11), 2366-2369. https://doi.org/10.3201/eid2911.230149.

Genetic Characterization of Extensively Drug-Resistant Shigella sonnei Infections, Spain, 2021–2022 [PDF - 938 KB - 4 pages]
C. Jacqueline et al.

In 2022, the United Kingdom reported an increase in drug resistance in Shigella sonnei isolates. We report 33 cases in Spain genetically related to the UK cases and 4 cases with similar antimicrobial resistance profiles infected with genetically distant strains. Our results suggest circulation of multiple genetic clusters of multidrug-resistant S. sonnei in Spain.

EID Jacqueline C, Carrascoso G, Gutiérrez-Fernández J, Rangel T, Goterris L, Valdes F, et al. Genetic Characterization of Extensively Drug-Resistant Shigella sonnei Infections, Spain, 2021–2022. Emerg Infect Dis. 2023;29(11):2370-2373. https://doi.org/10.3201/eid2911.221746
AMA Jacqueline C, Carrascoso G, Gutiérrez-Fernández J, et al. Genetic Characterization of Extensively Drug-Resistant Shigella sonnei Infections, Spain, 2021–2022. Emerging Infectious Diseases. 2023;29(11):2370-2373. doi:10.3201/eid2911.221746.
APA Jacqueline, C., Carrascoso, G., Gutiérrez-Fernández, J., Rangel, T., Goterris, L., Valdes, F....Herrera-Leon, S. (2023). Genetic Characterization of Extensively Drug-Resistant Shigella sonnei Infections, Spain, 2021–2022. Emerging Infectious Diseases, 29(11), 2370-2373. https://doi.org/10.3201/eid2911.221746.
Research Letters

Severe Rickettsia typhi Infections, Costa Rica [PDF - 435 KB - 3 pages]
D. Chinchilla et al.

Murine typhus is a febrile, fleaborne disease caused by infection with Rickettsia typhi bacteria. Cases can range from mild and nonspecific to fatal. We report 2 cases of murine typhus in Costa Rica, confirming the presence and circulation of R. typhi causing severe disease in the country.

EID Chinchilla D, Sánchez I, Chung I, Gleaton AN, Kato CY. Severe Rickettsia typhi Infections, Costa Rica. Emerg Infect Dis. 2023;29(11):2374-2376. https://doi.org/10.3201/eid2911.221561
AMA Chinchilla D, Sánchez I, Chung I, et al. Severe Rickettsia typhi Infections, Costa Rica. Emerging Infectious Diseases. 2023;29(11):2374-2376. doi:10.3201/eid2911.221561.
APA Chinchilla, D., Sánchez, I., Chung, I., Gleaton, A. N., & Kato, C. Y. (2023). Severe Rickettsia typhi Infections, Costa Rica. Emerging Infectious Diseases, 29(11), 2374-2376. https://doi.org/10.3201/eid2911.221561.

New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March–May 2023 [PDF - 625 KB - 4 pages]
M. J. Mwanga et al.

We report a newly emerged SARS-CoV-2 Omicron subvariant FY.4 that has mutations Y451H in spike and P42L in open reading frame 3a proteins. FY.4 emergence coincided with increased SARS-CoV-2 cases in coastal Kenya during April–May 2023. Continued SARS-CoV-2 genomic surveillance is needed to identify new lineages to inform COVID-19 outbreak prevention.

EID Mwanga MJ, Lambisia AW, Morobe J, Murunga N, Moraa E, Ndwiga L, et al. New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March–May 2023. Emerg Infect Dis. 2023;29(11):2376-2379. https://doi.org/10.3201/eid2911.230894
AMA Mwanga MJ, Lambisia AW, Morobe J, et al. New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March–May 2023. Emerging Infectious Diseases. 2023;29(11):2376-2379. doi:10.3201/eid2911.230894.
APA Mwanga, M. J., Lambisia, A. W., Morobe, J., Murunga, N., Moraa, E., Ndwiga, L....Githinji, G. (2023). New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March–May 2023. Emerging Infectious Diseases, 29(11), 2376-2379. https://doi.org/10.3201/eid2911.230894.

Genomic Sequencing Surveillance to Identify Respiratory Syncytial Virus Mutations, Arizona, USA [PDF - 634 KB - 3 pages]
L. A. Holland et al.

We conducted surveillance of respiratory syncytial virus (RSV) genomic sequences for 100 RSV-A and 27 RSV-B specimens collected during November 2022–April 2023 in Arizona, USA. We identified mutations within prefusion F-protein antigenic sites in both subtypes. Continued genomic surveillance will be critical to ensure RSV vaccine effectiveness.

EID Holland LA, Holland SC, Smith MF, Leonard VR, Murugan V, Nordstrom L, et al. Genomic Sequencing Surveillance to Identify Respiratory Syncytial Virus Mutations, Arizona, USA. Emerg Infect Dis. 2023;29(11):2380-2382. https://doi.org/10.3201/eid2911.230836
AMA Holland LA, Holland SC, Smith MF, et al. Genomic Sequencing Surveillance to Identify Respiratory Syncytial Virus Mutations, Arizona, USA. Emerging Infectious Diseases. 2023;29(11):2380-2382. doi:10.3201/eid2911.230836.
APA Holland, L. A., Holland, S. C., Smith, M. F., Leonard, V. R., Murugan, V., Nordstrom, L....Lim, E. S. (2023). Genomic Sequencing Surveillance to Identify Respiratory Syncytial Virus Mutations, Arizona, USA. Emerging Infectious Diseases, 29(11), 2380-2382. https://doi.org/10.3201/eid2911.230836.

Domestically Acquired NDM-1–Producing Pseudomonas aeruginosa, Southern California, USA, 2023 [PDF - 580 KB - 4 pages]
H. K. Gray et al.

We describe a case of New Delhi metallo-β-lactamase 1–producing carbapenem-resistant Pseudomonas aeruginosa (CRPA) in a transplant patient with multiple hospitalizations in California, USA. Whole-genome sequencing revealed the isolate was genetically distinctive, despite ≈95% similarity to other global strains. The patient’s lack of international travel suggests this CRPA was acquired domestically.

EID Gray HK, Beaird OE, Smith EA, Schaenman JM, Yang S. Domestically Acquired NDM-1–Producing Pseudomonas aeruginosa, Southern California, USA, 2023. Emerg Infect Dis. 2023;29(11):2382-2385. https://doi.org/10.3201/eid2911.230646
AMA Gray HK, Beaird OE, Smith EA, et al. Domestically Acquired NDM-1–Producing Pseudomonas aeruginosa, Southern California, USA, 2023. Emerging Infectious Diseases. 2023;29(11):2382-2385. doi:10.3201/eid2911.230646.
APA Gray, H. K., Beaird, O. E., Smith, E. A., Schaenman, J. M., & Yang, S. (2023). Domestically Acquired NDM-1–Producing Pseudomonas aeruginosa, Southern California, USA, 2023. Emerging Infectious Diseases, 29(11), 2382-2385. https://doi.org/10.3201/eid2911.230646.

Plasmodium vivax Prevalence in Semiarid Region of Northern Kenya, 2019 [PDF - 523 KB - 3 pages]
W. O’Meara et al.

In urban and rural areas of Turkana County, Kenya, we found that 2% of household members of patients with Plasmodium falciparum infections were infected with P. vivax. Enhanced surveillance of P. vivax and increased clinical resources are needed to inform control measures and identify and manage P. vivax infections.

EID O’Meara W, Maraga L, Meredith H, Esimit D, Lokoel G, Chepkwony T, et al. Plasmodium vivax Prevalence in Semiarid Region of Northern Kenya, 2019. Emerg Infect Dis. 2023;29(11):2385-2387. https://doi.org/10.3201/eid2911.230299
AMA O’Meara W, Maraga L, Meredith H, et al. Plasmodium vivax Prevalence in Semiarid Region of Northern Kenya, 2019. Emerging Infectious Diseases. 2023;29(11):2385-2387. doi:10.3201/eid2911.230299.
APA O’Meara, W., Maraga, L., Meredith, H., Esimit, D., Lokoel, G., Chepkwony, T....Obala, A. (2023). Plasmodium vivax Prevalence in Semiarid Region of Northern Kenya, 2019. Emerging Infectious Diseases, 29(11), 2385-2387. https://doi.org/10.3201/eid2911.230299.

Case Report and Literature Review of Prosthetic Cardiovascular Mucormycosis [PDF - 612 KB - 3 pages]
B. Hoellinger et al.

We report a rare case of aorto-bi-iliac prosthetic allograft mucormycosis in a 57-year-old immunocompetent patient in France. Outcome was favorable after surgery and dual antifungal therapy with liposomal amphotericin B and isavuconazole. In a literature review, we identified 12 other cases of prosthetic vascular or heart valve mucormycosis; mortality rate was 38%.

EID Hoellinger B, Magnus L, Ruch Y, Ohana M, Hansmann Y, Letscher-Bru V, et al. Case Report and Literature Review of Prosthetic Cardiovascular Mucormycosis. Emerg Infect Dis. 2023;29(11):2388-2390. https://doi.org/10.3201/eid2911.230837
AMA Hoellinger B, Magnus L, Ruch Y, et al. Case Report and Literature Review of Prosthetic Cardiovascular Mucormycosis. Emerging Infectious Diseases. 2023;29(11):2388-2390. doi:10.3201/eid2911.230837.
APA Hoellinger, B., Magnus, L., Ruch, Y., Ohana, M., Hansmann, Y., Letscher-Bru, V....Danion, F. (2023). Case Report and Literature Review of Prosthetic Cardiovascular Mucormycosis. Emerging Infectious Diseases, 29(11), 2388-2390. https://doi.org/10.3201/eid2911.230837.

Changes in Group A Streptococcus emm Types Associated with Invasive Infections in Adults, Spain, 2023 [PDF - 533 KB - 3 pages]
A. Bellés-Bellés et al.

An increase in invasive group A Streptococcus infection was detected in the northeast of Spain in November 2022. A postpandemic decline in the diversity of circulating emm types involved in invasive group A Streptococcus was observed, along with the emergence of emm49 in this geographic area.

EID Bellés-Bellés A, Prim N, Mormeneo-Bayo S, Villalón-Panzano P, Valiente-Novillo M, Jover-Sáenz A, et al. Changes in Group A Streptococcus emm Types Associated with Invasive Infections in Adults, Spain, 2023. Emerg Infect Dis. 2023;29(11):2390-2392. https://doi.org/10.3201/eid2911.230857
AMA Bellés-Bellés A, Prim N, Mormeneo-Bayo S, et al. Changes in Group A Streptococcus emm Types Associated with Invasive Infections in Adults, Spain, 2023. Emerging Infectious Diseases. 2023;29(11):2390-2392. doi:10.3201/eid2911.230857.
APA Bellés-Bellés, A., Prim, N., Mormeneo-Bayo, S., Villalón-Panzano, P., Valiente-Novillo, M., Jover-Sáenz, A....García-González, M. (2023). Changes in Group A Streptococcus emm Types Associated with Invasive Infections in Adults, Spain, 2023. Emerging Infectious Diseases, 29(11), 2390-2392. https://doi.org/10.3201/eid2911.230857.

SARS-CoV-2 Infection in Wrestlers after International Tournaments, April 2021 [PDF - 551 KB - 3 pages]
S. Kuribayashi et al.

Epidemiologic and genomic investigation of SARS-CoV-2 infections in members of Japan’s national wrestling team after participation in international tournaments in 2021 revealed multiple lineages of SARS-CoV-2 not reported in Japan. The attack rate among wrestlers was high. Results suggest possible transmission during matches. We recommend early case detection and response practices.

EID Kuribayashi S, Kasamatsu A, Ikenoue C, Fukusumi M, Kamiya H, Shimada T, et al. SARS-CoV-2 Infection in Wrestlers after International Tournaments, April 2021. Emerg Infect Dis. 2023;29(11):2393-2395. https://doi.org/10.3201/eid2911.230278
AMA Kuribayashi S, Kasamatsu A, Ikenoue C, et al. SARS-CoV-2 Infection in Wrestlers after International Tournaments, April 2021. Emerging Infectious Diseases. 2023;29(11):2393-2395. doi:10.3201/eid2911.230278.
APA Kuribayashi, S., Kasamatsu, A., Ikenoue, C., Fukusumi, M., Kamiya, H., Shimada, T....Sunagawa, T. (2023). SARS-CoV-2 Infection in Wrestlers after International Tournaments, April 2021. Emerging Infectious Diseases, 29(11), 2393-2395. https://doi.org/10.3201/eid2911.230278.

Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022 [PDF - 1.19 MB - 3 pages]
S. Nizamuddin et al.

Salmonella Typhi infection in a patient in Pakistan initially responded to standard treatment but failed to respond to subsequent treatment. The first strain was susceptible to carbapenems and azithromycin; subsequent strains harbored the NDM-5 gene. Treatment with a combination of intravenous meropenem and colistin was successful. Carbapenem-resistant Salmonella Typhi emergence will hinder treatment.

EID Nizamuddin S, Khan E, Chattaway M, Godbole G. Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022. Emerg Infect Dis. 2023;29(11):2395-2397. https://doi.org/10.3201/eid2911.230499
AMA Nizamuddin S, Khan E, Chattaway M, et al. Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022. Emerging Infectious Diseases. 2023;29(11):2395-2397. doi:10.3201/eid2911.230499.
APA Nizamuddin, S., Khan, E., Chattaway, M., & Godbole, G. (2023). Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022. Emerging Infectious Diseases, 29(11), 2395-2397. https://doi.org/10.3201/eid2911.230499.

Ceftazidime/Avibactam Resistance in Carbapenemase-Producing Klebsiella pneumoniae [PDF - 779 KB - 3 pages]
Q. Cui et al.

We identified a novel ceftazidime/avibactam resistance mechanism in sequence type 11 Klebsiella pneumoniae carbapenemase 2–producing K. pneumoniae. Plasmid recombination and chromosomal integration formed a novel virulence plasmid and provided an additional promoter for blaSHV-12, leading to blaSHV-12 overexpression and ceftazidime/avibactam resistance. Genetic rearrangement contributed to convergence of hypervirulence and ceftazidime/avibactam resistance.

EID Cui Q, Wang C, Wang Q, Qin J, Li M, Ding B, et al. Ceftazidime/Avibactam Resistance in Carbapenemase-Producing Klebsiella pneumoniae. Emerg Infect Dis. 2023;29(11):2398-2400. https://doi.org/10.3201/eid2911.230830
AMA Cui Q, Wang C, Wang Q, et al. Ceftazidime/Avibactam Resistance in Carbapenemase-Producing Klebsiella pneumoniae. Emerging Infectious Diseases. 2023;29(11):2398-2400. doi:10.3201/eid2911.230830.
APA Cui, Q., Wang, C., Wang, Q., Qin, J., Li, M., Ding, B....Shen, Z. (2023). Ceftazidime/Avibactam Resistance in Carbapenemase-Producing Klebsiella pneumoniae. Emerging Infectious Diseases, 29(11), 2398-2400. https://doi.org/10.3201/eid2911.230830.

Refractory Microascus Bronchopulmonary Infection Treated with Olorofim, France [PDF - 492 KB - 3 pages]
E. Faure et al.

We report 3 cases of successful treatment of Microascus spp. bronchopulmonary infection in a multiple-traumatized patient and 2 lung transplant recipients in France. We emphasize the promising use of olorofim antifungal therapy in a rising context of intrinsically less-susceptible respiratory infections caused by mold.

EID Faure E, Brugière O, de Verdiere S, Vuotto F, Limousin L, Cardot E, et al. Refractory Microascus Bronchopulmonary Infection Treated with Olorofim, France. Emerg Infect Dis. 2023;29(11):2401-2403. https://doi.org/10.3201/eid2911.230984
AMA Faure E, Brugière O, de Verdiere S, et al. Refractory Microascus Bronchopulmonary Infection Treated with Olorofim, France. Emerging Infectious Diseases. 2023;29(11):2401-2403. doi:10.3201/eid2911.230984.
APA Faure, E., Brugière, O., de Verdiere, S., Vuotto, F., Limousin, L., Cardot, E....Lanternier, F. (2023). Refractory Microascus Bronchopulmonary Infection Treated with Olorofim, France. Emerging Infectious Diseases, 29(11), 2401-2403. https://doi.org/10.3201/eid2911.230984.

Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana [PDF - 681 KB - 4 pages]
C. Modongo et al.

GeneXpert MTB/RIF, a tool widely used for diagnosing tuberculosis, has limitations for detecting rifampin resistance in certain variants. We report transmission of a pre–extensively drug-resistant variant in Botswana that went undetected by GeneXpert. The public health impact of misdiagnosis emphasizes the need for comprehensive molecular testing to identify resistance and guide treatment.

EID Modongo C, Barilar I, Wang Q, Molefi T, Makhondo T, Niemann S, et al. Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana. Emerg Infect Dis. 2023;29(11):2403-2406. https://doi.org/10.3201/eid2911.230987
AMA Modongo C, Barilar I, Wang Q, et al. Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana. Emerging Infectious Diseases. 2023;29(11):2403-2406. doi:10.3201/eid2911.230987.
APA Modongo, C., Barilar, I., Wang, Q., Molefi, T., Makhondo, T., Niemann, S....Shin, S. S. (2023). Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana. Emerging Infectious Diseases, 29(11), 2403-2406. https://doi.org/10.3201/eid2911.230987.

Scedosporium Infection in Recipients of Kidney Transplants from Deceased Near-Drowning Donor [PDF - 602 KB - 3 pages]
D. Choudhary et al.

Scedosporium aurianticum infection developed in 2 recipients of kidney transplants in India, acquired from the same deceased near-drowning donor. Given the substantial risk for death associated with Scedosporium infection among solid-organ transplant recipients, safety protocols for organ transplantation from nearly drowned donors should be thoroughly revaluated and refined.

EID Choudhary D, Kaur H, Subramani V, Pattanaik S, Patil SS, Sethi J, et al. Scedosporium Infection in Recipients of Kidney Transplants from Deceased Near-Drowning Donor. Emerg Infect Dis. 2023;29(11):2406-2408. https://doi.org/10.3201/eid2911.231000
AMA Choudhary D, Kaur H, Subramani V, et al. Scedosporium Infection in Recipients of Kidney Transplants from Deceased Near-Drowning Donor. Emerging Infectious Diseases. 2023;29(11):2406-2408. doi:10.3201/eid2911.231000.
APA Choudhary, D., Kaur, H., Subramani, V., Pattanaik, S., Patil, S. S., Sethi, J....Sharma, A. (2023). Scedosporium Infection in Recipients of Kidney Transplants from Deceased Near-Drowning Donor. Emerging Infectious Diseases, 29(11), 2406-2408. https://doi.org/10.3201/eid2911.231000.
Letters

Investigation of Possible Link between Interferon-α and Lyme Disease [PDF - 194 KB - 1 page]
A. Alaedini et al.
EID Alaedini A, Crow MK, Fallon BA, Jacek E, Wormser GP. Investigation of Possible Link between Interferon-α and Lyme Disease. Emerg Infect Dis. 2023;29(11):2409. https://doi.org/10.3201/eid2911.230839
AMA Alaedini A, Crow MK, Fallon BA, et al. Investigation of Possible Link between Interferon-α and Lyme Disease. Emerging Infectious Diseases. 2023;29(11):2409. doi:10.3201/eid2911.230839.
APA Alaedini, A., Crow, M. K., Fallon, B. A., Jacek, E., & Wormser, G. P. (2023). Investigation of Possible Link between Interferon-α and Lyme Disease. Emerging Infectious Diseases, 29(11), 2409. https://doi.org/10.3201/eid2911.230839.
Books and Media

Viruses: A Natural History [PDF - 374 KB - 1 page]
S. S. Morse
EID Morse SS. Viruses: A Natural History. Emerg Infect Dis. 2023;29(11):2410. https://doi.org/10.3201/eid2911.231225
AMA Morse SS. Viruses: A Natural History. Emerging Infectious Diseases. 2023;29(11):2410. doi:10.3201/eid2911.231225.
APA Morse, S. S. (2023). Viruses: A Natural History. Emerging Infectious Diseases, 29(11), 2410. https://doi.org/10.3201/eid2911.231225.
Corrections

Correction: Vol. 29, No. 3 [PDF - 374 KB - 1 page]
EID Correction: Vol. 29, No. 3. Emerg Infect Dis. 2023;29(11):2410. https://doi.org/10.3201/eid2911.c12911
AMA Correction: Vol. 29, No. 3. Emerging Infectious Diseases. 2023;29(11):2410. doi:10.3201/eid2911.c12911.
APA (2023). Correction: Vol. 29, No. 3. Emerging Infectious Diseases, 29(11), 2410. https://doi.org/10.3201/eid2911.c12911.
About the Cover

A Turbulent Cloud, a Viral Menace [PDF - 2.52 MB - 2 pages]
B. Breedlove
EID Breedlove B. A Turbulent Cloud, a Viral Menace. Emerg Infect Dis. 2023;29(11):2411-2412. https://doi.org/10.3201/eid2911.ac2911
AMA Breedlove B. A Turbulent Cloud, a Viral Menace. Emerging Infectious Diseases. 2023;29(11):2411-2412. doi:10.3201/eid2911.ac2911.
APA Breedlove, B. (2023). A Turbulent Cloud, a Viral Menace. Emerging Infectious Diseases, 29(11), 2411-2412. https://doi.org/10.3201/eid2911.ac2911.
Page created: October 20, 2023
Page updated: November 02, 2023
Page reviewed: November 02, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external